# LLM call: summary

- Turn: 6
- Sequence: 12
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 783
- Completion tokens: 239
- Total tokens: 1135
- Cost (USD): 0.000127

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1418: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
First-half 2028 productivity studies and cold venture left InvestAI's distressed salvage of hyperscale sites as the sovereignty bet, but municipal moratorium and court injunctions on power/water kept the salvaged site frozen with slipping deliveries and unchanged Gigafactory completion.

Autumn 2028 added biosecurity alarm: a genome-model study claimed AI-assisted non-experts could reach viable human-infecting designs, read by health officials as categorically new despite methodological dispute. In response the Union closed its two-year commitment: ordered screening refits for hospitals/labs finished and signed off, while HERA/ECDC launched a new surge — wastewater/clinical sequencing in shield regions, triage exercises, joint countermeasure procurement.

Washington shifted with November election of a coalition-oriented president promising structured allied access, joint evaluation/incident reporting and relaxed tiering for export-control alignment; Brussels kept volume licences alive without pre-inauguration concessions. Neither Brussels track unfroze in-turn: Competitiveness Council benefit template went into court-supervised mediation holding but not lifting sites/grid, transatlantic side-letter again yielded no fast lane. Harm-reporting desk expansion with falling waits and resilient segmented grid operators contained fallout and kept the biology paper out of front pages.

CURRENT NARRATIVE:
### The pads go quiet
The court order landed in February. What had been temporary injunctions on power and water around the salvaged hyperscale site became a lasting zoning restriction. Engineers demobilised, grid reservations were released at a loss, and the mediation the Competitiveness Council had shepherded was closed. Host-region papers called it a write-down; the Commission called it an orderly retreat.

Brussels did not promise new concrete. InvestAI funds were redirected to unfrozen locations and to the accelerated-permitting zones created under the tech sovereignty package, which formally closed this period. Officials stressed permits granted and private capital mobilised, but no new site could absorb the lost capacity in-turn. Re-siting studies slipped, costs rose. The closed package was still booked as adding to the authoritative stock, lifting measured sovereignty to 22 even as usable capacity remained exposed.

### Washington opens a door, but nothing signed
The November election winner took office in January promising structured allied access on published terms. Trade officials carried the old side-letter into a formal track with the incoming administration: volume licences extended, talks on joint evaluation, incident reporting and export-control alignment begun.

Nothing was signed in this half-year. American staff were still being appointed, and alignment on controls and standards proved harder than the campaign language. Brussels kept access alive without conceding, but also without securing the published guarantee it sought. The continued dialogue avoided a rupture and lent modest legitimacy at home, but the weight of the unfunded portfolio — Gigafactories, tech package, compute assurance track and bio surge — left political capital down on the half-year, with no win to bank.

The bio leg held steadier. Sequencing, triage exercises and joint procurement continued in shield regions, and the harm-reporting desk kept waiting times down. A contested genome-model study circulated more widely among journalists, prompting uneasy coverage but no front-page scare.

By June, the Union had survived the loss without collapse — cushioned by finished refits, a segmented grid, and an American partner willing to talk — but essential workloads remained exposed, and the public mood soured on the sight of empty pads.
```

## Raw response

```
Early 2028 salvage of hyperscale sites collapsed when February court order made power/water injunctions a lasting zoning restriction: engineers demobilised, grid reservations released at loss, mediation closed. InvestAI redirected to unfrozen sites and accelerated-permitting zones as tech sovereignty package formally closed; booked stock lifted measured sovereignty to 22 but usable capacity stayed exposed with slipping re-siting and rising costs, Gigafactory completion unchanged.

Autumn 2028 biosecurity alarm over genome-model study persisted with wider journalist circulation but no front-page scare; Union's screening refits, HERA/ECDC surge — sequencing, triage, joint procurement in shield regions — plus expanded harm-reporting desk and segmented grid contained fallout.

New US president inaugurated in January promising structured allied access; volume licences extended and formal talks on joint evaluation/incident reporting/export-control alignment began, but nothing signed amid staffing and standards disputes. Brussels avoided rupture or concessions without securing published guarantee, leaving political capital down under weight of unfunded Gigafactories, tech package, compute assurance and bio surge.
```
